UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia

Figure 3

(a) The scores of PLS-DA for hyperlipidemia with syndrome of SLQSD group and hyperlipidemia with syndrome of non-SLQSD group in positive ion mode [R2Y(cum)=0.996, Q2(cum)=0.722]. (b) The scores of PLS-DA for hyperlipidemia with syndrome of SLQSD group and hyperlipidemia with syndrome of non-SLQSD group in negative ion mode [R2Y(cum)=0.85, Q2(cum)=0.719]. (c) The loading plots derived from UPLC-QTOF/MS data for plasma samples of hyperlipidemia with syndrome of SLQSD group and hyperlipidemia with syndrome of non-SLQSD group in positive ion mode. (d) The loading plots derived from UPLC-QTOF/MS data for plasma samples of hyperlipidemia with syndrome of SLQSD group and hyperlipidemia with syndrome of non-SLQSD group in negative ion mode.

(a)

(b)

(c)

(d)